Incidence of tumour cells in lymphatics as effect of breast conservation surgery for breast cancer patinets
Phase 3
- Conditions
- Health Condition 1: null- Operable Breast Cancer Female patient
- Registration Number
- CTRI/2017/11/010589
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 700
Inclusion Criteria
1.Female patient with breast cancer age 18 years and above
2.T1 N0 / T2 N0 tumours
3.Patient undergoing upfront breast conserving surgery
4.Willing to give consent to participate in the study
Exclusion Criteria
1.Previous h/o lumpectomy or incision biopsy
2.Patient planned for Neoadjuvant Chemotherapy
3.Locally advanced or metastatic breast tumours
4.Lactating patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the incidence of Iatrogenic Displacement of Tumor Cells in afferent lymphatics as a consequence of tumor handlingTimepoint: 30 days after surgery
- Secondary Outcome Measures
Name Time Method 1.To study the incidence of micrometastases in afferent lymphatics as a consequence of tumor handling <br/ ><br>Timepoint: From the day of surgery to post operative Day 15;2.To study the impact of ITCs on disease free survivalTimepoint: 5 years